Atsushi Takeda, MD, PhD
Affiliations: | Medical Biochemistry | Tohoku University, Sendai-shi, Miyagi-ken, Japan |
Area:
http://www.biomedexperts.com/Profile.bme/1388341/Atsushi_TakedaWebsite:
http://www.labome.org/expert/japan/university/takeda/atsushi-takeda-195538.htmlGoogle:
"Atsushi Takeda"Mean distance: 18.77 (cluster 28) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree - Chemistry Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kanno S, Shinohara M, Kanno K, et al. (2020) Neural substrates underlying progressive micrographia in Parkinson's disease. Brain and Behavior. e01669 |
Gang M, Baba T, Hosokai Y, et al. (2020) Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society |
Baba T, Takeda A. (2020) Cognitive impairment and its association with cholinergic dysfunction in Parkinson’s disease Neurology and Clinical Neuroscience |
Kobayashi J, Hasegawa T, Sugeno N, et al. (2019) Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802051R |
Ezura M, Kikuchi A, Ishiki A, et al. (2019) Longitudinal changes in F-THK5351 PET in corticobasal syndrome. European Journal of Neurology |
Nomoto M, Nagai M, Nishikawa N, et al. (2018) Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease. Eneurologicalsci. 13: 8-13 |
Hattori N, Takeda A, Takeda S, et al. (2018) Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan. Parkinsonism & Related Disorders |
Nishio Y, Yokoi K, Hirayama K, et al. (2018) Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions. Parkinsonism & Related Disorders |
Hattori N, Takeda A, Takeda S, et al. (2018) Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter study. Parkinsonism & Related Disorders |
Yoshida S, Hasegawa T, Suzuki M, et al. (2018) Parkinson's disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking. Human Molecular Genetics |